Sera Prognostics Adds New Senior Executive
September 22, 2021
Sera Prognostics Inc., The Pregnancy Company™ (NASDAQ: SERA) will add a new doc to the team. Dr. Michael R. Foley has been appointed to the position of Chief Medical Officer starting in January 2022.
Salt Lake City-based Sera Prognostics focuses on neonatal health as well as maternal health using biomarker information. Using PreTRM® test reports, physicians can predict individualized risk of spontaneous premature delivery in a pregnancy, making early proactive intervention possible.
Dr. Foley has previously worked in a private maternal-fetal medicine practice for over 20 years as well as Chairman of Obstetrics and Gynecology at the University of Arizona College of Medicine Phoenix/Banner Good Samaritan Regional Medical Center, where he has served for over 1o years.
Recent News
- Canyon Labs Launches Expanded Reprocessing Validation Services for Medical Devices
- Connecting with Life Sciences in Logan
- Halia Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
- Ratio Therapeutics Enters into Research Collaboration, License Agreement with RayzeBio to Advance a Novel Radiopharmaceutical Program
- Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida
- Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
